CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
ProdromeNeuro Omega 3 Oil Nutritional Supplementdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04484454
NCT04484454N/ACompleted

ProdromeNeuro: An Open-Label Study of Omega 3 Oil Nutritional Supplementation for Aging-Related Cognitive Decline

Neurological Associates of West Los Angeles·interventional·Posted Jul 23, 2020·Updated Jun 7, 2021

In Brief

A clinical study evaluating ProdromeNeuro Omega 3 Oil Nutritional Supplement for Cognitive Decline. Completed, enrolled 20 participants across 1 site.

Detailed Summary

Aging-related cognitive decline may be affected by brain cholesterol and the health of cell membranes. Certain nutritional supplements have been proposed to support membrane health, and there is increasing interest in plasmalogens and Omega-3 derived oil supplements to support brain health among older adults. The product being investigated in this study is the ProdromeNeuro Omega 3 oil nutritional supplement. This product contains naturally occurring fatty acids in higher concentrations than similar products that are commercially available. The purpose of this research study is to better understand the effects of ProdromeNeuro Omega-3 nutritional supplementation among subjects with age-related cognitive decline.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsProdrome Sciences

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJul 23, 2020
Enrollment StartJul 17, 2020
Primary CompletionMar 13, 2021
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 5.9 years ago

Interventions

ProdromeNeuro Omega 3 Oil Nutritional Supplementdietary

ProdromeNeuro is an algae-derived Omega 3 oil nutritional supplement product comprised of naturally occurring alkylglycerol and natural fatty acids. ProdromeNeuro functions as a natural plasmalogen precursor which can be administered orally.